Singapore markets closed

Esperion Therapeutics, Inc. (0ET.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.9410-0.2260 (-10.43%)
As of 08:10AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-86,507
-209,248
-233,659
-269,108
-143,551
-
Depreciation & amortisation
83
164
500
612
547
-
Stock-based compensation
12,290
11,958
15,215
24,306
28,385
-
Change in working capital
-1,109
13,675
-3,373
-52,513
-4,262
-
Accounts receivable
-18,197
-14,765
-10,795
-10,546
-12,388
-
Inventory
-33,743
-30,422
-807
-18,258
-16,136
-
Accounts payable
11,203
8,678
5,603
-34,099
23,106
-
Other working capital
-27,376
-135,487
-174,827
-263,809
-98,546
-
Other non-cash items
48,013
48,376
46,211
35,528
33,801
-
Net cash provided by operating activities
-27,303
-135,487
-174,827
-263,809
-85,177
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-13,369
-953
Purchases of investments
-
0
-59,897
-50,484
-4,420
-
Sales/maturities of investments
17,500
42,500
68,001
0
39,145
-
Net cash used for investing activities
17,427
42,500
8,104
-50,484
21,356
-
Cash flows from financing activities
Debt repayment
-
-
0
-440
-8,405
0
Common stock issued
0
56,876
90,849
218,688
0
-
Common stock repurchased
-
-
-
0
-55,000
0
Dividends paid
0
0
0
0
0
-
Other financing activities
-
-
-50,219
49,602
25,000
124,424
Net cash used provided by (used for) financing activities
91,574
50,460
32,606
268,223
201,725
-
Net change in cash
81,698
-42,527
-134,117
-46,070
137,904
-
Cash at beginning of period
144,911
124,775
258,892
304,962
167,058
-
Cash at end of period
226,609
82,248
124,775
258,892
304,962
-
Free cash flow
Operating cash flow
-27,303
-135,487
-174,827
-263,809
-85,177
-
Capital expenditure
-
-
-
-
-13,369
-953
Free cash flow
-27,376
-135,487
-174,827
-263,809
-98,546
-